5 results
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
his tenure at UCL Business, and has worked in business development roles at Thiologics, Canbex and Eli Lilly. He has also worked in research roles … of Juno Therapeutics, Inc. from 2015 through its acquisition by Celgene in 2018. Earlier, during a 15-year tenure at Amgen, Mr. Azelby served in commercial
6-K
EX-1
AUTL
Autolus Therapeutics plc
26 May 20
Current report (foreign)
4:31pm
. During his tenure at Janssen, he also oversaw all regulatory aspects of the company’s Ebola vaccine and therapeutic product development, as well as leading
20-F
2018 FY
AUTL
Autolus Therapeutics plc
23 Nov 18
Annual report (foreign)
12:00am
. In this role, Mr. Hacker was responsible for leading regulatory activities across all scientific innovation projects. During his tenure at Janssen, he also
F-1/A
EX-10.6
AUTL
Autolus Therapeutics plc
8 Jun 18
Registration statement (foreign) (amended)
6:25am
of, and in connection with, your tenure as a director or officer of the Company, whether actual or contingent, direct or indirect and irrevocably
- Prev
- 1
- Next